Stock FUSN FUSN PHAR
Add to a list
To use this feature you must be a member
Log inSign up

Other languages FUSN PHAR

Equities

FUSN

CA36118A1003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
21.48 USD -0.09% Intraday chart for FUSN PHAR -0.14% +123.52%
May. 09 Fusion Pharmaceuticals Inc. Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer CI
May. 07 Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fusion Pharmaceuticals Inc. Announces First Patient Dosed in the Phase 2 Portion of the AlphaBreak Trial Evaluating FPI-2265 in Metastatic Castration-Resistant Prostate Cancer
Fusion Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Fusion Pharmaceuticals Inc. Presents Interim Efficacy and Safety Data from the Phase 2 TATCIST Open-Label Clinical Trial Evaluating FPI-2265
Fusion Pharmaceuticals Narrows Q4 Loss; Enters Sale Deal With AstraZeneca
Fusion Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Fusion Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Sector Update: Health Care Stocks Rise Late Afternoon
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading
Sector Update: Health Care
Top Midday Gainers
Top Stories at Midday: February US Housing Starts Rise; AstraZeneca to Acquire Fusion Pharmaceuticals; IFF to Sell Pharma Solutions Unit; Unilever to Spin Off Ice Cream Unit; MicroStrategy Completes Notes Offering; Super Micro Computer Files Shelf; Nvidia Unveils Latest GPU
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected
Sector Update: Health Care
Fed Policy Meeting in Focus as Exchange-Traded Funds, Equity Futures Fall Pre-Bell Tuesday
US Futures Trend Lower in Tuesday's Premarket as Investors Await Start of 2-Day Fed Meeting
Top Premarket Gainers
AstraZeneca Strikes $2.4 Billion Deal to Buy Fusion Pharmaceuticals
Fusion Pharmaceuticals Signs Licensing Deal, Settles Patent Dispute
Top Premarket Gainers
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FUSN Stock
  4. News FUSN PHAR
  5. Other languages